Cargando…
Difluprednate for the prevention of ocular inflammation postsurgery: an update
PURPOSE: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%. METHODS: A comprehensive search of recent published literature including difluprednate was performed. Clinical studies relevant to the characteristics and clinical efficacy...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130919/ https://www.ncbi.nlm.nih.gov/pubmed/21750615 http://dx.doi.org/10.2147/OPTH.S6541 |